Media 19 Jun 2019 Orthocell’s CelGro bone regeneration device accelerates dental implant treatment timeframes, cuts costs Small Caps has featured the outcomes of Orthocell's single-stage dental implant study, evaluating treatment with our CelGro™ collagen membrane. Orthocell
Media 28 May 2019 Bell Potter launches placement for Orthocell Orthcell's planned equity raise has been featured in AFR's Street Talk. Orthocell
Media 14 May 2019 Orthocell shares spike 350% following interim results of Celgro nerve regeneration study Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients… Orthocell
Media, Video 26 Oct 2018 Channel 7 | Ortho-ATI™ Feature Story Channel 7 News Perth has showcased Orthocell’s successful tendon treatment therapy for AFL star Daniel Kerr. Orthocell
Media, Video 30 Jun 2018 Video | Channel 9 News Report – Ortho-ATIâ„¢ – June 2018 Channel 9 News has featured Orthocell's Ortho-ATIâ„¢ as part of its nightly news coverage. Orthocell
Media 16 Jun 2018 Move over miners, Perth’s next hard cell is bio-manufacturers Orthocell has been featured in the Weekend Australian this week as one of two Perth companies transforming the state’s economic… Orthocell
Media 14 Jun 2018 Orthocell highlights its novel ability to treat tennis elbow Positive results from Orthocell's study into its novel tendon cell therapy treatment for tennis elbow have been featured in Small… Orthocell
Media 01 May 2018 Orthocell looks forward to strong European market after successful clinical study Small Caps has reported on a successful clinical study showing our CelGroâ„¢ medical device improves dental bone regeneration. Orthocell
Media, Video 13 Dec 2017 Video | CommSec Interview – December 2017 Orthcell CEO and Managing Director, Paul Anderson, speaks with CommSec's Tom Piotrowski about the company’s two key products, its recently… Orthocell
Media, Video 05 Jan 2016 Video | AusBiotech Interview – January 2016 Orthocell CEO & Managing Director, Paul Anderson, explains the unique technology behind the company's cellular regenerative medicine, and in particular… Orthocell